CTU A Multicenter, Open Label, Non-Randomized First-in-Human Phase I/II Study to Assess the Safety, Tolerability, PK, PD and Preliminary Anti-Tumor Activity of DB1303 in Subjects with Advanced Solid Malignant Tumors

  • Sabanathan, Dhanusha (Primary Chief Investigator)
  • Chester, Catherine (Clinical Trial Unit Staff)
  • Chapman, Nicola (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleDB-1303-O-1001
AcronymDB-1303-O-1001
StatusActive
Effective start/end date16/05/22 → 4/04/27